RENAL FUNCTION, LIVER FUNCTION, AND LIPID PROFILE STATE IN SUBJECTS AFTER HEALING FROM COVID-19 INFECTION

Main Article Content

Israa H. Ibrahim
Mena Y. Abd
Murtadha Matai Al-Fatlawi
Murtadha Matai Al-Fatlawi

Keywords

Coronavirus, COVID-19, liver function

Abstract

Background: Coronavirus belongs to the Coronaviridae family, Nidovirales order. Coronaviruses are separated into four genera and β- COVs only infect mammals. Human COVs consist of α- COVs (229E and NL63), β- COVs (OC43 and HKU1), the Middle East respiratory syndrome-related coronavirus (MERS-COV), and SARS-COV.


Aim of Study: to evaluate the effect of infection with coronavirus on liver and renal function and also the effect on lipid profile according to the duration after healing.


Materials and Methods: the persons were divided according to the duration after healing to ≤3, ≤6, >6 months, and the human samples were taken from a private laboratory for renal function, liver function, and lipid profile.


Results: the results show a significant increase in S.ALT, S.AST, and S.TSB in some groups and there were no significant differences in other parameters.


In conclusion there was no effect of COVID-19 on the function of the kidney as well as lipid profile but may have a reversible effect on liver function and the needs for more long-term studies are very important.

Abstract 111 | pdf Downloads 68

References

1. Abdullah Ali Mohammed, Mahmood Nazar Mustafa, Sura A. Abdulsattar, Ahmed Salam Al-zaidi. (2021) COVID 19: Evaluate of Liver and Renal Function Tests in Iraqi Patients. Medico-legal Update, Vol. 21, No. 1.
2. Herget-Rosenthal S, Bokenkamp A, Hofmann W (2007) How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem 40:153–161. https:// doi. org/ 10. 1016/j. Clin Biochem. 2006. 10. 014.
3. Xinhua. China’s CDC detects a large number of new coronaviruses in the South China seafood market in Wuhan. Available from: URL:
https://www.xinhuanet.com/2020-01/27/c_1125504355.htm. Accessed, February 20, 2020.)
4. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med.; 367(19):1814-1820
5. Zhong NS, Zheng BJ, Li YM, et al. (2003) Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China. Lancet, 362(9393):1353-1358.
6. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798): 270–3
7. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. (2020) China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China. N Engl J Med, 382(8): 727–33.
8. Marchiori JS, de Oliveira MAS, Bezerra IMP. (2021) COVID-19 and its relationship with kidney diseases: a scoping review. J Hum Growth Dev. 31(3):533-548. DOI:10.36311/jihad.v31.12782.
9. Noori Ali, Roaa; Fadhil Alasadi, Yusor; Isam Jameel, Zahraa (2021) Estimation some Kidney function parameters among COVID-19 Patients in Kerbala province. Archivos Venezolanos de Farmacología y Terapéutica, vol. 40, núm. 7, Sociedad Venezolana de Farmacología Clínica y Terapéutica, República Bolivariana de Venezuela Disponible en:
https://www.redalyc.org/articulo.oa?id=55971545014
10. Grzywa-Celińska, A., Emeryk-Maksymiuk, J., Szewczyk, K., Krusiński, A., Celiński, R., Milanowski, J. (2021). Acute liver injury in the course of COVID-19. Ann Agric Environ Med., 28(4), 729-732. https://doi.org/10.26444/aaem/142232
11. Elghannam, M. T., Hassanien, M. H., Ameen, Y. A., ELattar, G. M., ELRay, A. A., Turky, E. A., & ELTalkawy, M. D. (2022). COVID-19 and liver diseases. Egyptian Liver Journal, 12(1), 1-9. https://doi.org/10.1186/s43066-022-00202-2.
12. Abdelrahman, M. M., Younis, M. A., Mahmoud, M. G., & Shafik, N. S. (2021). Liver function test abnormalities in COVID-19 patients and factors affecting them – a retrospective study. Clinical and Experimental Hepatology, 7(3), 297-304. https://doi.org/10.5114/ceh.2021.109225.
13. Cai, Q., Huang, D., Yu, H., Zhu, Z., Xia, Z., Su, Y., Li, Z., Zhou, G., Gou, J., Qu, J., Sun, Y., Liu, Y., He, Q., Chen, J., Liu, L., & Xu, L. (2020). COVID-19: Abnormal liver function tests. Journal of hepatology, 73(3), 566–574. https://doi.org/10.1016/j.jhep.2020.04.006.
14. Liao, X., Li, D., Ma, Z., Zhang, L., Zheng, B., Li, Z., Li, G., Liu, L., & Zhang, Z. (2022). 12-Month Post-Discharge Liver Function Test Abnormalities Among Patients With COVID-19: A Single-Center Prospective Cohort Study. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.864933.
15. Zhu X, Wang J, Du J, Chen S, Chen S, Li J, Shen B. (2022) Changes in Serum Liver Function for Patients with COVID-19: A 1-Year Follow-Up Study. Infect Drug Resist. 15:1857-1870
https://doi.org/10.2147/IDR.S356181.
16. Almas, T., Malik, J., Alsubai, A. K., Ehtesham, M., Laique, T., Ishaq, U., Mehmood, A., Jawad Zaidi, S. M., Hadeed, S., Huang, H., & Oruk, M. (2022). Effect of COVID-19 on lipid profile parameters and its correlation with acute phase reactants: A single-center retrospective analysis. Annals of Medicine and Surgery, 78, 103856. https://doi.org/10.1016/j.amsu.2022.103856
17. Changaripour, S., Sarvazad, H., Barghi, M., Sajadi, E., Sadeghian, M. H., & Roozbahani, N. E. (2022). Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study. Journal of International Medical Research. https://doi.org/10.1177/03000605221078699